- Home
- Publications
- Publication Search
- Publication Details
Title
Renal cell cancer: overview of the current therapeutic landscape
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 16, Issue 9, Pages 955-968
Publisher
Informa UK Limited
Online
2016-08-22
DOI
10.1080/14737140.2016.1222908
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Stage T3a renal cell carcinoma: staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion
- (2015) H K Sokhi et al. BRITISH JOURNAL OF RADIOLOGY
- Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Controversies in renal cell carcinoma: Treatment choice after progression on vascular endothelial growth factor-targeted therapy
- (2014) Emiliano Calvo et al. EUROPEAN JOURNAL OF CANCER
- Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
- (2014) Daniel Y.C. Heng et al. EUROPEAN UROLOGY
- Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study
- (2014) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
- (2014) Steffen Durinck et al. NATURE GENETICS
- Robotic radical nephrectomy for renal cell carcinoma: a systematic review
- (2014) Anastasios D Asimakopoulos et al. BMC Urology
- The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
- (2013) John R. Srigley et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial
- (2013) D Cella et al. BRITISH JOURNAL OF CANCER
- Five-Year Survival in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma Treated With Axitinib
- (2013) Brian I. Rini et al. Clinical Genitourinary Cancer
- A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
- (2013) Cora N. Sternberg et al. EUROPEAN JOURNAL OF CANCER
- Dysregulation of the mammalian target of rapamycin pathway in chromophobe renal cell carcinomas
- (2013) Alcides Chaux et al. HUMAN PATHOLOGY
- Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma
- (2013) Thomas E. Hutson et al. JOURNAL OF CLINICAL ONCOLOGY
- Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial
- (2013) Robert J Motzer et al. LANCET ONCOLOGY
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI?
- (2012) Emiliano Calvo et al. CANCER TREATMENT REVIEWS
- The VHL/HIF axis in clear cell renal carcinoma
- (2012) Chuan Shen et al. SEMINARS IN CANCER BIOLOGY
- Renal Cell Carcinoma Deep Sequencing: Recent Developments
- (2012) Leslie J. Farber et al. Current Oncology Reports
- Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression
- (2011) Jeff A Klomp et al. BMC Medical Genomics
- The Glycolytic Shift in Fumarate-Hydratase-Deficient Kidney Cancer Lowers AMPK Levels, Increases Anabolic Propensities and Lowers Cellular Iron Levels
- (2011) Wing-Hang Tong et al. CANCER CELL
- Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
- (2011) Judith Manola et al. CLINICAL CANCER RESEARCH
- Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
- (2011) Brian I Rini et al. LANCET
- Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
- (2011) F. M. Yakes et al. MOLECULAR CANCER THERAPEUTICS
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- Tumor Biology and Prognostic Factors in Renal Cell Carcinoma
- (2011) D. S. Finley et al. ONCOLOGIST
- Whole-body MRI in follow-up of patients with renal cell carcinoma
- (2010) Ivan Platzek et al. ACTA RADIOLOGICA
- Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma
- (2010) Min-Han Tan et al. BMC CANCER
- Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab
- (2010) Jorge A. Garcia et al. CANCER
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology and risk factors for kidney cancer
- (2010) Wong-Ho Chow et al. Nature Reviews Urology
- Significance of18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma
- (2009) Jong Wook Park et al. BJU INTERNATIONAL
- Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer
- (2009) S A SOHAIB et al. BRITISH JOURNAL OF RADIOLOGY
- Development and evaluation of BioScore
- (2009) Alexander S. Parker et al. CANCER
- Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Renal Cell Carcinoma Correlates with Prognosis
- (2009) K. Bluemke et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
- (2009) Giuseppe Di Lorenzo et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
- (2009) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma
- (2009) M.P. Sablin et al. JOURNAL OF UROLOGY
- Effect of Warm Ischemia Time During Laparoscopic Partial Nephrectomy on Early Postoperative Glomerular Filtration Rate
- (2009) Guilherme Godoy et al. JOURNAL OF UROLOGY
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
- (2009) Martin E Gore et al. LANCET ONCOLOGY
- Paraneoplastic Syndromes in Patients with Urological Malignancies
- (2009) Emilio Sacco et al. UROLOGIA INTERNATIONALIS
- Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005)
- (2008) Arie S. Belldegrun et al. CANCER
- Sequential therapy with sorafenib and sunitinib in renal cell carcinoma
- (2008) Arkadiusz Z. Dudek et al. CANCER
- Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma
- (2008) Robert J. Motzer et al. CANCER
- High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma
- (2008) Jacob A. Klapper et al. CANCER
- Survivin Expression in Renal Cell Carcinoma
- (2008) Rosanna Zamparese et al. CANCER INVESTIGATION
- Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
- (2008) Christian Eichelberg et al. EUROPEAN UROLOGY
- Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881
- (2008) Jan H.M. Blom et al. EUROPEAN UROLOGY
- Axitinib for renal cell carcinoma
- (2008) Guru Sonpavde et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Active Surveillance of Renal Masses in Elderly Patients
- (2008) Robert Abouassaly et al. JOURNAL OF UROLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- Management of the Incidental Renal Mass
- (2008) Stuart G. Silverman et al. RADIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started